Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2006
10/19/2006US20060234367 Yeast cells; ribonuclease barnase marker gene; libraries; drug resistance
10/19/2006US20060234352 Homogeneity and secretion of recombinant proteins in mammalian systems
10/19/2006US20060234344 Protein kinases
10/19/2006US20060234343 deletion of residues in the CR2 domain of the EGFR ectodomain gives rise to a truncated ectodomain with enhanced affinity for epidermal growth factors such as (EGF) and/or transforming growth factor-I (TGF- alpha ); psoriasis and tumor states
10/19/2006US20060234342 Human DNA topoisomerase I alpha
10/19/2006US20060234339 Method of expressing protein having unnatural amino acid integrated thereinto
10/19/2006US20060234311 Isolating cells expressing secreted proteins
10/19/2006US20060234310 Enriched antigen-specific T-cells and related therapeutic and prophylactic compositions and methods
10/19/2006US20060234296 Method for generating high affinity antibodies
10/19/2006US20060234289 Sp110, a polypeptide component of the nuclear body
10/19/2006US20060234280 Enyzmes having alpha amylase activity and methods of making and using them
10/19/2006US20060234275 Method for collecting purified cells
10/19/2006US20060234232 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same
10/19/2006US20060234217 Nucleic acid encodes a heat labile alkaline phosphatase, or the complementary sequence
10/19/2006US20060234211 Arterivirus (RNA enveloped virus); polypeptides with sensitivity and specificity; decreasing the incidence of false positives in a diagnostic assay
10/19/2006US20060233855 Administering a synthetic polymer ( biodegradable, nonbiodegradable polymers e.g. polylactic acid, PTFE) attached to denatured, uncleaved fibrinogen being subject to proteolytic and hydrolytic degradation in a patient in need of bone tissue, thereby regenerating the bone or cartilage tissues
10/19/2006US20060233854 Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
10/19/2006US20060233840 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
10/19/2006US20060233839 Novel compounds
10/19/2006US20060233822 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof
10/19/2006US20060233819 Inhibition of T cell activation by butyrophilin 4 or B7-L1
10/19/2006US20060233818 Organic compounds
10/19/2006US20060233808 Peptabody for cancer treatment
10/19/2006US20060233802 Tumour necrosis factor binding ligands
10/19/2006US20060233801 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures
10/19/2006US20060233796 Method of modulating memory effector T-cells and compositions
10/19/2006US20060233795 Methods for selectively modulating a Th2-type response within a population of activated CD4+ T cells
10/19/2006US20060233787 Human cd3-specific antibody with immunosuppressive properties
10/19/2006US20060233771 Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands
10/19/2006US20060233770 a human cell line, which lacks major histocompatibility class I (MHC-I) and class II (MHC-II) antigens, has been modified to comprise and express a nucleotide sequence encoding an immunomodulator, and a nucleotide sequence encoding an antigen of Epstein-Barr virus
10/19/2006US20060233769 Established cell line of microglia
10/19/2006US20060233768 Elective collection and banking of autologous peripheral blood stem cells
10/19/2006US20060233765 Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
10/19/2006US20060233764 Skin regeneration system
10/19/2006US20060233763 Cartilaginous cell culture medium and the use thereof
10/19/2006US20060233760 Splicing variant of TGF-beta2 and uses thereof
10/19/2006US20060233758 Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
10/19/2006US20060233757 Vectors with viral insulators
10/19/2006US20060233751 Population of natural cells, 50% are autoantigen-specific regulatory T cells
10/19/2006US20060233750 Materials and method of modulating the immune response
10/19/2006US20060233745 Enclosures housing cell-coated supports for treating tumors
10/19/2006US20060233744 Orthogonal tRNA synthetase that aminoacylates with reduced efficiency; lower km and recognizes selector codon in mRNA
10/19/2006DE102005017551A1 Recovery, preparation and storage of stem cells from umbilical cord blood, useful e.g. for autologous treatment of anemias, cancer, AIDS and thalassemia
10/19/2006CA2604697A1 In vitro production of a cell population using feeder cells
10/19/2006CA2604493A1 Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
10/19/2006CA2604423A1 Modified animal lacking functional pyy gene, monoclonal antibodies that bind pyy isoforms and uses therefor
10/19/2006CA2604377A1 Compositions and methods for the diagnosis and treatment of tumor
10/19/2006CA2604330A1 Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines
10/19/2006CA2604135A1 Pop2 nfkb-inhibiting polypeptides, nucleic acids and methods of use
10/19/2006CA2603863A1 Gammaretrovirus associated with cancer
10/19/2006CA2603779A1 Chimeric proteins comprising yersinia yop, their preparation and pharmaceutical compositions containing them
10/19/2006CA2603453A1 5-fluorouracil-resistant bacteria and method for production thereof
10/19/2006CA2583027A1 Serum-free cell culture medium for mammalian cells
10/18/2006EP1712631A2 Fc receptors and polypeptides
10/18/2006EP1712628A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
10/18/2006EP1712626A1 Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same
10/18/2006EP1712624A1 Ires functioning in plant
10/18/2006EP1712620A1 Peptide originating in epidermal growth factor receptor (egfr)
10/18/2006EP1712616A1 Induction of myocardial cell with the use of mammalian bone marrow cell or cord blood-origin cell and fat tissue
10/18/2006EP1712615A1 In vitro production of a cell population using feeder cells
10/18/2006EP1712565A1 Cell death inducing agents
10/18/2006EP1712563A1 Method of isolating monocytes
10/18/2006EP1712561A1 Silk thread containing spider thread protein and silkworm producing the silk thread
10/18/2006EP1712243A1 Gene therapy for tumor using minus-strand rna viral vectors encoding immunostimulatory cytokines
10/18/2006EP1711613A2 Gene silencing by using micro-rna molecules
10/18/2006EP1711608A1 Differentiation regulating agent containing gene which regulating differentiation from stem cells into natural killer cells as effective ingredient
10/18/2006EP1711599A1 Embryonic stem cell line and method for preparing the same
10/18/2006EP1711598A1 Method for isolating and culturing multipotent progenitor/stem cells from umbilical cord blood and method for inducing differentiation thereof
10/18/2006EP1711597A2 Human hepatic progenitor cells and methods of use thereof
10/18/2006EP1711596A1 A method and apparatus for orienting spherical cells
10/18/2006EP1711595A2 Use of polysulphated alginate in cellular matrices
10/18/2006EP1711594A1 Novel culture systems for ex vivo development
10/18/2006EP1711531A2 Neutralizing antibodies and methods of use thereof
10/18/2006EP1711530A2 Nogo-a neutralising immunoglobulins for treatment of neurological diseases
10/18/2006EP1711517A2 MUTANT SODIUM CHANNEL NAv1.7 AND METHODS RELATED THERETO
10/18/2006EP1711052A1 Mouse model for psoriasis and psoriatic arthritis
10/18/2006EP1556481B1 Method for activating dendritic cells
10/18/2006EP1543329A4 Cell-based fluorescence resonance energy transfer (fret) assays for clostridial toxins
10/18/2006EP1527158B1 Advanced roller bottle system for cell and tissue culturing
10/18/2006EP1481063B1 Delta 6-desaturases from primulaceae, expressing plants and pufa-containing oils
10/18/2006EP1448595B1 Antimicrobial polypeptides from pseudoplectania nigrella
10/18/2006EP1389236B1 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof
10/18/2006EP1358332B1 A serpin in bifidobacteria
10/18/2006EP1337636B1 Soluble zcytor 11 cytokine receptors
10/18/2006EP1326654B1 Methods and compositions for tissue regeneration
10/18/2006EP1280821B1 Dna molecules encoding ligand gated ion channels from dermacentor variabilis
10/18/2006EP1272203B1 Treatment of neurodegenerative gastrointestinal disorders by implanting neural stem cells and/or progeny thereof into gastrointestinal organs
10/18/2006EP1262557B1 Parkin protein as ubiquitin ligase
10/18/2006EP1210411B1 Compositions and methods for improved cell culture
10/18/2006EP1208196B1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
10/18/2006EP1165778B1 Uses of casb618 polynucleotides and polypeptides
10/18/2006EP1144666B1 Replication deficient baculovirus expression system
10/18/2006EP1144611B1 Method for recombinant protein production in mammalian cells comprising co-expression with fetuin
10/18/2006EP1141286B1 Cytokine receptor chain
10/18/2006EP1131434B1 Apoptosis-inducing factor
10/18/2006EP1119611B1 Composition for use in chemonucleolysis
10/18/2006EP1071710B1 Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma
10/18/2006EP1042468B1 Low-voltage activated calcium channel compositions and methods
10/18/2006EP1038008B1 Methods for producing egiii-like enzymes
10/18/2006EP1019500B1 Ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons